1. Home
  2. MTVA vs JL Comparison

MTVA vs JL Comparison

Compare MTVA & JL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTVA
  • JL
  • Stock Information
  • Founded
  • MTVA 2014
  • JL 1985
  • Country
  • MTVA United States
  • JL Hong Kong
  • Employees
  • MTVA N/A
  • JL N/A
  • Industry
  • MTVA
  • JL
  • Sector
  • MTVA
  • JL
  • Exchange
  • MTVA NYSE
  • JL NYSE
  • Market Cap
  • MTVA 16.8M
  • JL 14.6M
  • IPO Year
  • MTVA N/A
  • JL 2024
  • Fundamental
  • Price
  • MTVA $1.60
  • JL $4.91
  • Analyst Decision
  • MTVA Strong Buy
  • JL
  • Analyst Count
  • MTVA 1
  • JL 0
  • Target Price
  • MTVA $12.00
  • JL N/A
  • AVG Volume (30 Days)
  • MTVA 23.0K
  • JL 336.7K
  • Earning Date
  • MTVA 03-27-2025
  • JL 03-25-2025
  • Dividend Yield
  • MTVA N/A
  • JL 3.87%
  • EPS Growth
  • MTVA N/A
  • JL N/A
  • EPS
  • MTVA N/A
  • JL 0.54
  • Revenue
  • MTVA N/A
  • JL $32,831,195.00
  • Revenue This Year
  • MTVA N/A
  • JL N/A
  • Revenue Next Year
  • MTVA N/A
  • JL N/A
  • P/E Ratio
  • MTVA N/A
  • JL $9.09
  • Revenue Growth
  • MTVA N/A
  • JL N/A
  • 52 Week Low
  • MTVA $1.51
  • JL $0.23
  • 52 Week High
  • MTVA $6.75
  • JL $29.95
  • Technical
  • Relative Strength Index (RSI)
  • MTVA N/A
  • JL 52.26
  • Support Level
  • MTVA N/A
  • JL $3.28
  • Resistance Level
  • MTVA N/A
  • JL $6.50
  • Average True Range (ATR)
  • MTVA 0.00
  • JL 0.76
  • MACD
  • MTVA 0.00
  • JL 0.03
  • Stochastic Oscillator
  • MTVA 0.00
  • JL 50.62

About MTVA METAVIA INC

MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

About JL J-LONG GROUP LIMITED

J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.

Share on Social Networks: